ArticleRSC advances2026
Osteoinductive scaffolds composed of dual functionalized polylysine functionalized calcium phosphate graphene.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone regeneration remains a major clinical challenge due to limitations in the bioactivity, mechanical compatibility, and controlled resorbability of current interventions. Functional graphenic materials (FGMs) provide a tunable platform for bone-regenerative scaffolds, yet strategies to incorporate multiple bioactive functionalities while preserving their chemical and mechanical properties remain limited. Here, we developed a dual-functionalized calcium phosphate and poly(l-lysine) graphenic material (pKCaPG) designed to combine osteoinductive ion release with enhanced cell-material interactions. To accomplish this, poly(l-lysine) was grafted onto Claisen-modified graphene prior to calcium phosphate functionalization through an Arbuzov reaction, enabling sequential functionalization while preserving labile polyphosphate groups. Chemical characterization confirmed successful dual functionalization, while pKCaPG retained calcium and phosphate release comparable to calcium phosphate graphene and, with shorter poly(l-lysine) chains, maintained its compressive properties. In human bone marrow-derived mesenchymal stem cells, pKCaPG significantly increased alkaline phosphatase activity and mineral deposition relative to admixed controls and osteogenic media. Together, these results demonstrate that complementary bioactive functionalities can be integrated onto a graphenic scaffold without compromising key material properties and establish pKCaPG as a multifunctional platform for bone regeneration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.